CMMB
Chemomab Therapeutics
CMMB
CMMB
14 hedge funds and large institutions have $22.7M invested in Chemomab Therapeutics in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
37% less capital invested
Capital invested by funds: $35.9M → $22.7M (-$13.2M)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$599K | |
| 2 | +$155K | |
| 3 | +$79.3K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$78K |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.1K |
Top Sellers
| 1 | -$356K | |
| 2 | -$138K | |
| 3 | -$102K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.7K |
| 5 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$6K |